Zimmer Biomet Holdings Inc. is a global leader in musculoskeletal healthcare, dedicated to alleviating pain and improving the quality of life for patients worldwide. The company's mission revolves around innovation in orthopedic and dental solutions, focusing on advanced technologies and surgical products. Zimmer Biomet's strategy emphasizes strategic partnerships, research and development, and a commitment to enhancing patient outcomes through comprehensive solutions. With a diverse portfolio of products and a strong presence in the global market, Zimmer Biomet operates with the goal of transforming the healthcare landscape and providing exceptional value to healthcare providers and patients alike.

ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet Holdings, Inc. is making a strategic move to strengthen its position in the orthopedic market through the acquisition of Paragon 28, Inc. for approximately $1.1 billion. The acquisition deal, which is expected to close in the first half of 2025, involves an upfront payment of $13 per share,...

Zimmer Biomet to Acquire Paragon 28 for $1.1 Billion to Strengthen Foot and Ankle Orthopedics Division

Zimmer Biomet's strategic acquisition of Paragon 28 for $1.1 billion signals a bold move into the lucrative foot and ankle orthopedic market, projected to reach $5 billion. As the landscape shifts towards ambulatory surgery centers, can this deal unlock new growth opportunities for Zimmer?